Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 5, Number 6—December 1999

HIV Infection as a Risk Factor for Shigellosis1

Jefferson T. Baer*, Duc J. Vugia*†‡, Arthur L. Reingold*§, Tomas Aragon¶, Frederick J. Angulo#, and Williamson Z. Bradford*§**Comments to Author 
Author affiliations: *California Emerging Infections Program, San Francisco, California, USA; †California Department of Health Services, Berkeley, California, USA; ‡University of California, San Francisco, California, USA; §School of Public Health, University of California, Berkeley, California, USA; ¶San Francisco Department of Public Health, San Francisco, California, USA; #Centers for Disease Control and Prevention, Atlanta, Georgia, USA; and **IntraBiotics Pharmaceuticals, Mountain View, California, USA

Main Article

Table 1

Persons with shigellosis, by county of residence, 1996

Characteristic San Francisco (n = 228) Alameda (n = 140) p value
Male 157/228 (69%) 60/140 (43%) <0.001
Age >18 181/227 (80%) 57/140 (41%) <0.001

White 117/200 (59%) 15/92 (16%) <0.001

Black 39/200 (20%) 44/92 (48%) <0.001

Hispanic 37/200 (19%) 22/92 (24%) 0.285
Hospitalized 22/201 (11%) 12/140 (9%) 0.472
HIV infection 66/168 (39%) 9/125 (7%) <0.001
Foreign travel 25/185 (14%) NAa
Gay male 96/190 (51%) NAa
Recent sex 70/136 (51%) NAa

aNA = not available

Main Article

1Presented in part at the International Conference on Emerging Infections, March 1998, Atlanta, Georgia.

Page created: December 16, 2010
Page updated: December 16, 2010
Page reviewed: December 16, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.